Home ›
Breast Cancer Trials ›
NCT07612254
aPBI Re-irradiation
This study is to determine whether acute treatment-associated adverse events following breast re-irradiation with aPBI are acceptably low and to assess local control following breast re-irradiation with aPBI. An exploratory aim is to assess cosmetic outcomes following breast re-irradiation with aPBI.
Trial Details
NCT ID NCT07612254
Phase PHASE1 / PHASE2
Sponsor Dartmouth-Hitchcock Medical Center
Status RECRUITING
Cancer Type Breast Cancer
Interventions
Locations (sample) Lebanon, New Hampshire, United States|43.64229,-72.25176
Key Eligibility Criteria
Patients who have histologically-confirmed, second, ipsilateral breast cancer which was diagnosed more than one year after completing breast conser… Patients must have received prior radiotherapy to the breast Patients must have an intact, involved breast. Patients must meet ASTRO 2023 guidelines for a strong recommendation for partial breast irradiation.
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Breast Cancer Trials on Trialify →